Pharmaceuticals Financial News

buy call on Biocon with a target price of Rs 430. The current market price of Biocon is Rs 382.8. Biocon, incorporated in 1978, is a Large Cap company with a market cap of Rs 45970.97 crore, operating in the pharmaceuticals sector. Biocon's key products/revenue segments include Bio Pharmaceuticals, Other Operating Revenue, Waste and Sale of services for the year ending 31-Mar-2024.

Axis Securities has an overweight call on Lupin with a target price of Rs 2600. The current market price of Lupin is Rs 2160. Lupin, incorporated in 1983, is a Large Cap company with a market cap of Rs 99094.85 crore, operating in the pharmaceuticals sector. Lupin's key products/revenue segments include Pharmaceuticals, Other Services, Export Incentives, Other Operating Revenue and Scrap for the year ending 31-Mar-2024.

Shares of Biocon Ltd.(up 6.15 per cent), Divi's Laboratories Ltd.(up 4.5 per cent), Natco Pharma Ltd.(up 3.7 per cent), Granules India Ltd.(up 2.78 per cent) and Mankind Pharma Ltd.(up 2.7 per cent) ended the day as top gainers in the pack.

On the BSE, Sangam Renewables(down 20.00 per cent), Sayaji Hotels(down 16.05 per cent), Welspun Investments (down 15.12 per cent), Empire Ind(down 14.45 per cent) and Spectrum Foods(down 13.82 per cent) stood among the top losers in today's trade.

stocks rallied as much as 15% in Mumbai trading on Monday even as equity benchmarks, BSE Sensex and NSE Nifty, traded in the amid brisk in frontline bluechip counters. Stocks that surged in excess of 15% included, Sri Chakra Cement(20.00%), Palash Securities(17.18%), Centenial Surg(16.23%) and AVI Products India (15.81%).

Subscribe to enjoy similar stories. BENGALURU : Asia Pacific-focused private equity firm PAG has acquired a majority stake in Pravesha Industries Pvt.

Subscribe to enjoy similar stories. New Delhi: The Parliamentary Standing Committee on Chemicals and Fertilizers reviewed the prices of essential medicines on 7 January in a meeting attended by officials from the Department of Pharmaceuticals (DoP). This move may lead to a lowering of prices of life-saving medicines.

Newron Pharmaceuticals S.p.A. and Myung In Pharm Co. Ltd. on Friday announced that they have entered into a license agreement to develop, manufacture and commercialize Newron’s innovative modulator of the excessive release of glutamate, evenamide, an add-on therapy for treatment-resistant schizophrenia (TRS) and poorly responding patients with schizophrenia, in South Korea.

US penny stocks in January 2025 itself.

Standard Glass Lining IPO is likely to be finalised later today or tomorrow morning. Investors will get shares on a lottery basis and the whole process was supervised by the registrar. On the allotment date, investors get to know about the number of shares allotted to them as against the bids made. They can check the allotment status through the BSE or by visiting the registrar's website. Here's how you can check the status on BSE or even on the registrar's website.

Shares of Dr. Reddy's Laboratories Ltd.(up 1.43 per cent) ended the day as top gainers in the pack.

Indian pharmaceutical industry is aiming to more than double its size to USD 120-130 billion by 2030 as it looks to ride on the back of innovation to become the healthcare custodian of the world, Indian Pharmaceutical Alliance (IPA) president and Torrent Group chairman Samir Mehta said. In the last 25 years, the Indian pharma industry has grown nearly 20 times — a market size of USD 58 billion from USD 3 billion in 1999-2000, contributing equally to domestic sales and exports today. The sector is among the top five contributors to India's trade surplus, which has grown to USD 19.5 billion from merely USD 1 billion in 1999-2000.

Jagsonpal Pharmaceuticals had announced a stock split in the ratio of 1:2.5 and fixed January 8 as the record date for determining the shareholder eligibility, which makes today the last day to buy the stock to qualify for the split offer. “Pursuant to Regulation 42 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, it is hereby informed that, the Board of Directors of the Company has passed the necessary resolution through Circular Resolution, on Tuesday, December 17, 2024 and has fixed the record date on Wednesday, January 8, 2025 for the purpose of Sub-division/Split of equity shares of the Company such that 1 (one) equity share having face value of Rs. 5/- (Rupees five only) each, fully paid-up, be sub-divided into such number of equity shares having face value of Rs. 2 (Rupee two only) each,” the company had said in a previous exchange filing.

Subscribe to enjoy similar stories. Before his sons dismantled the company he had meticulously built, tarnishing the reputation of a proud business dynasty, Parvinder “Pammi" Singh was regarded as a legend in Indian business. Unlike first-generation entrepreneurs, Parvinder inherited Ranbaxy—a modest pharma business his father, Bhai Mohan Singh, had acquired from its founders, Ranbir Singh and Gurbax Singh.

ICICI Prudential Mutual Fund (MF), Kotak MF, Tata MF, Motilal Oswal MF, 3P Investment Managers, Kotak Infinity Fund — Class AC, ITI MF, Massachusetts Institute of Technology, Amansa Holdings, and Clarus Capital were anchor investors, according to a circular uploaded on BSE website. According to the circular, Standard Glass Lining Technology Ltd has allotted 87.86 lakh shares to 10 entities at Rs 140 per equity share, which is also the upper end of the price band. This aggregates the transaction size to Rs 123.01 crore.

Gland Pharma Ltd.(up 3.18 per cent) and J B Chemicals & Pharmaceuticals Ltd.(up 1.1 per cent) were among the top gainers.

The NSE Nifty index closed 445.75 points up at 24188.65, while BSE Sensex ended 1436.3 points at 79943.71.

Shares of Ipca Laboratories Ltd.(up 3.02 per cent), Granules India Ltd.(up 1.88 per cent), Gland Pharma Ltd.(up 1.77 per cent), Zydus Lifesciences Ltd.(up 1.75 per cent) and Glenmark Pharmaceuticals Ltd.(up 1.54 per cent) ended the day as top gainers in the pack.

The NSE Nifty index ended the session 445.75 points up at 24188.65, while BSE Sensex 1436.3 points to 79943.71.

Ipca Laboratories Ltd.(up 1.19 per cent), Biocon Ltd.(up 0.91 per cent), Gland Pharma Ltd.(up 0.66 per cent), Dr. Reddy's Laboratories Ltd.(up 0.49 per cent) and Granules India Ltd.(up 0.48 per cent) were among the top gainers.